Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Lloyd M. L. Smyth"'
Autor:
Andrew W. See, Patrick Bowden, Geoffrey Wells, Sree Appu, Nathan Lawrentschuk, Peter Liodakis, Chloe Pandeli, Yolanda Aarons, Lloyd M. L. Smyth, Dean P. McKenzie
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-10 (2022)
Abstract Background Dose-escalation to above 80 Gy during external beam radiotherapy for localised prostate cancer leads to improved oncological outcomes but also substantially increased rectal toxicity. The aim of this study was to demonstrate the s
Externí odkaz:
https://doaj.org/article/e673c3a3b4f2460bae153c915b2c8584
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-10 (2019)
Abstract Background The addition of regional nodal radiation (RNI) to whole breast irradiation for high risk breast cancer improves metastases free survival and new data suggests it contributes additional benefit to overall survival. Deep inspiration
Externí odkaz:
https://doaj.org/article/ec754b0b8b344f18a750c91380338e7e
Autor:
Verdiana Trappetti, Jean A. Laissue, Nahoko Shintani, Lloyd M. L. Smyth, David Haberthür, Cristian Fernandez-Palomo, Valentin Djonov, Duncan Butler, Micah Barnes, Michael John de Veer, Marie C. Vozenin, Mitzi Klein
Publikováno v:
Trappetti, Verdiana; Fernandez Palomo, Cristian; Smyth, Lloyd; Klein, Mitzi; Haberthür, David; Butler, Duncan; Barnes, Micah; Shintani, Nahoko; de Veer, Michael; Laissue, Jean A.; Vozenin, Marie C.; Djonov, Valentin (2021). Synchrotron Microbeam Radiotherapy for the treatment of lung carcinoma: a pre-clinical study. International journal of radiation oncology, biology, physics, 111(5), pp. 1276-1288. Elsevier 10.1016/j.ijrobp.2021.07.1717
Purpose In the last three decades, Synchrotron Microbeam Radiation Therapy (S-MRT) has been shown to achieve both good tumour control and normal tissue sparing in a range of pre-clinical animal models. However, the use of S-MRT for the treatment of l
Autor:
Elliot Anderson, Nathan Lawrentschuk, Lloyd M. L. Smyth, Jeremy Grummet, Richard O'Sullivan, Andrew Ryan, Andrew W. See
Publikováno v:
Transl Androl Urol
BACKGROUND: Focal treatment for prostate cancer (PCa) is a hybrid approach combining ablative treatment of the involved prostate gland and continued active surveillance (AS) of the unaffected gland. Low dose-rate (LDR) brachytherapy can be used as a
Autor:
Adam Landau, Jeremy Grummet, Nicholas Campbell, Ranjit Rao, Andrew W. See, Daniel Moon, Patrick Bowden, Lloyd M. L. Smyth, Alan Crosthwaite, Mark Frydenberg, Dean Philip McKenzie, Skye Nolan, Paul Ruljancich, Hodo Haxhimolla, Stella May Gwini, Declan G. Murphy, Dennis Gyomber, Dennis King, Nathan Lawrentschuk, Kevin So
Publikováno v:
World Journal of Urology
Purpose To evaluate outcomes for men with biochemically recurrent prostate cancer who were selected for transponder-guided salvage radiotherapy (SRT) to the prostate bed alone by 68Ga-labelled prostate-specific membrane antigen positron emission tomo
Autor:
Lloyd M. L. Smyth, Cameron J. Nowell, Leonie Cann, Liam R. J. Day, Peter Rogers, Jacqueline F. Donoghue, Helen B. Forrester, Jeffrey C. Crosbie, Jessica Ventura
Publikováno v:
International Journal of Radiation Biology. 97:642-656
γH2AX biodosimetry has been proposed as an alternative dosimetry method for microbeam radiation therapy (MRT) because conventional dosimeters, such as ionization chambers, lack the spatial resolution required to accurately measure the MRT valley dos
Autor:
Liam R. J. Day, Sashendra Senthi, Jeffrey C. Crosbie, Lloyd M. L. Smyth, Peter Rogers, Katrina Woodford
Publikováno v:
Physica Medica. 60:111-119
Purpose: Synchrotron Microbeam Radiation Therapy (MRT) is a pre-clinical modality characterised by spatial dose fractionation on a microscopic scale. Treatment planning studies using clinical datasets have not yet been conducted. Our aim was to inves
Autor:
Paolo Pellicioli, Lloyd M. L. Smyth, Liam R. J. Day, Jeffrey C. Crosbie, Mattia Donzelli, Stefan Bartzsch, Micah Barnes
Publikováno v:
Physics in medicine and biology. 66(5)
Synchrotron Radiotherapy (SyncRT) is a preclinical radiation treatment which delivers synchrotron x-rays to cancer targets. SyncRT allows for novel treatments such as Microbeam Radiotherapy, which has been shown to have exceptional healthy tissue spa
Autor:
Heidrun Janka, Lloyd M. L. Smyth, Jennifer Fazzari, Verdiana Trappetti, Cristian Fernandez-Palomo, Jean A. Laissue, Valentin Djonov
Publikováno v:
Cancers, Vol 12, Iss 3174, p 3174 (2020)
Fernandez-Palomo, Cristian; Fazzari, Jennifer Michelina; Trappetti, Verdiana; Smyth, Lloyd; Janka, Heidrun Ilonka; Laissue, Jean; Djonov, Valentin (2020). Erratum: Fernandez-Palomo, C., et al. Animal Models in Microbeam Radiation Therapy: A Scoping Review. Cancers 2020, 12, 527. Cancers, 12(11), p. 3174. MDPI AG 10.3390/cancers12113174
Fernandez-Palomo, Cristian; Fazzari, Jennifer Michelina; Trappetti, Verdiana; Smyth, Lloyd; Janka, Heidrun Ilonka; Laissue, Jean; Djonov, Valentin (2020). Erratum: Fernandez-Palomo, C., et al. Animal Models in Microbeam Radiation Therapy: A Scoping Review. Cancers 2020, 12, 527. Cancers, 12(11), p. 3174. MDPI AG 10.3390/cancers12113174
The authors wish to make the following corrections to this paper [...]
Publikováno v:
Radiation research. 196(4)
Synchrotron microbeam radiation therapy (MRT) is a preclinical irradiation technique which could be used to treat intracranial malignancies. The goal of this work was to discern differences in gene expression and the predicted regulation of molecular